[Calcium and pregnancy induced hypertension]

Area of Science:

• Obstetrics and Gynecology
• Nutritional Science
• Maternal Health

Context:

• Pregnancy-induced hypertension (PIH) is a significant concern in maternal health.
• Calcium metabolism plays a crucial role during pregnancy.
• Existing research suggests a potential link between calcium levels and PIH.

Purpose:

• To prospectively investigate the relationship between calcium supplementation and the incidence of pregnancy-induced hypertension (PIH).
• To determine the optimal dosage of calcium supplementation for PIH prevention.
• To assess the safety of calcium supplementation during pregnancy.

Summary:

• A prospective study involved 150 pregnant women divided into three groups receiving 0g, 1g, or 2g of calcium daily.
• The group receiving 2g of calcium daily exhibited the lowest PIH incidence (4%).
• An expanded study with 200 women in each group (2g calcium vs. no supplement) confirmed these findings, with PIH rates of 7.5% and 16.5% respectively.
• No adverse effects were reported with 2g daily calcium supplementation.

Impact:

• Calcium supplementation, particularly 2g daily, may be a beneficial strategy for reducing PIH incidence in pregnant women.
• This research provides evidence supporting the role of adequate calcium intake in preventing pregnancy complications.
• Findings can inform clinical guidelines and public health recommendations regarding prenatal nutrition.